Infection with hepatitis G virus among recipients of plasma products.
about
Hepatitis G virusIn vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virusDetection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR.Comparison of six sets of PCR primers from two different genomic regions for amplification of GB virus C/hepatitis G virus RNA.GB virus C/hepatitis G virus infection in HIV infected patients with haemophilia despite treatment with virus inactivated clotting factor concentratesHepatitis G virus infection in chronic liver diseaseHepatitis G virus infection in fulminant hepatic failureLack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G virusesGB Virus C/Hepatitis G Virus (GBV-C/HGV): still looking for a diseaseNew hepatitis viruses: contenders and pretendersHepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an updateDetection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypesPrevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, BrazilThe hepatic flaviviridae: summary.Pathogenicity of GBV-C/HGV infection.Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection.Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies.Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strainsGuidelines on the diagnosis, management and prevention of hepatitis in haemophilia.Epidemiology and prophylaxis of viral hepatitis: a global perspective.Infectious hepatitis C, hepatitis G, and TT virus: review and implications for dentists.Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs.TT viral infection through blood transfusion: retrospective investigation on patients in a prospective study of post-transfusion hepatitis.Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescentsHepatitis G virus infection in lymphoma and in blood donors.An overview about hepatitis C: a devastating virus.Role of GB virus C in modulating HIV diseasePrevalence and vertical transmission of human pegivirus among pregnant women infected with HIV.High prevalence of GB virus C/hepatitis G virus genotype 3 among autochthonous Venezuelan populations.GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4(+) T lymphocyte count.Current status of hepatitis G virus (GBV-C) in transfusion: is it relevant?A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany.HGV/GB virus C transmission by blood components in patients undergoing open-heart surgery.Seroprevalence of GB virus C and persistence of RNA and antibody.Hepatitis G virus infection in normal and prospectively followed posttransfusion children.Hepatitis G virus does not cause significant liver disease after liver transplantation.The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT Group.High prevalence of HGV/GBV-C infection in polytransfused patients with thalassemia major.GB virus C prevalence in blood donors and high risk groups for parenterally transmitted agents from Gauteng, South Africa.
P2860
Q24658258-6DF5D4FC-18C0-4179-B3EF-81169FF8396EQ27469359-36860701-0FF9-497E-84C6-CA417061CFDAQ27469557-85B87D8E-E50A-4EEA-ADFD-62C9723CAF6FQ27472606-4C9C3C29-008A-4884-9F68-3B38F2F9EF8BQ27477818-F5A20EC4-CB8D-4DD5-957E-E06599845753Q27477828-1B4A56DC-6897-4574-A6C8-B0E7E0DBFADEQ27480284-7BB52D29-E0EA-401B-ACF3-81CF395E35A7Q27480882-A7ECF4EE-4C6E-4808-8243-C0439E4EB6E2Q27486644-FB013AA3-DA86-4DE2-97E2-6646B4BF37ECQ28201488-0FA042A2-1AC8-4175-9C4C-707495EAE804Q28284989-47013C76-AFBE-48CA-9AF7-7F6108C33FDFQ33803759-CB8C9BCD-F066-4592-9D4C-55CC92B521ECQ33869199-F1C4258A-0569-4CBA-9357-D41EFB280ED6Q33888790-DC5E6280-D67A-455F-B9A5-48CF36D47CAAQ33888816-773CB7D9-40B6-4806-88A7-1A5A858C0F4CQ33957208-9F4F07D5-6F25-4541-8750-F7BEF0957313Q33960053-F8F23D4F-FC93-4350-9780-3C03A8BB3B5AQ34123551-132D7B7C-4F21-4789-9676-B2FD7EF8EE97Q34145972-75310D93-5645-4273-8CE6-03FF1988ACF1Q34301709-7E7BA523-47B8-4D16-B3F1-5E0D606B9C13Q34631380-ACF11D32-4EC6-4B60-BB9A-79C7B4BED855Q34729997-125E2CA5-92A4-4BDC-A298-E06466C47D37Q36150271-CC03C685-062B-4094-BEFA-8302824AFD1CQ36492178-EB2E941F-AFC9-4E96-A227-D66E4218D051Q36542411-B699531B-0C27-4B92-9993-19E4E2DB1B95Q37227252-4CD539C5-9918-4BA7-81DE-9E5495FE66B0Q37719516-1DFD585A-F2CF-45AD-8904-1358C619BA70Q38018981-D193BB62-8B8E-45DA-BB83-AC58AFAA09D6Q38845889-E0CA7D4D-AD86-4C43-995F-BCCB71C0A247Q39615387-E2C457B2-E370-497C-A700-7348F441E866Q40093263-086642BF-39EA-4938-99A5-63F55C6EE206Q41598085-C66BB40A-8398-481A-B7C9-C2014C63F0AEQ41882649-8D33EA92-2ECA-410F-A42D-47AE6D4E6015Q42981259-D7C96C60-2D75-43DE-BAC5-B9EEDC846826Q42985045-8A3B680F-6F22-4434-A3CC-E73EAB2B73FCQ42985794-80623D7D-AE58-4DF6-8CBC-F226BE1ECBEFQ42986744-D37D5710-73C4-4F54-ADEF-5CBB7788AEB6Q42987147-72554480-906F-47D7-9291-A1D1E602FEADQ42988061-95821090-F68C-4019-80F4-AD903C77BCE5Q42988106-293AE017-BEF7-4C7F-85C5-138B6CDC3669
P2860
Infection with hepatitis G virus among recipients of plasma products.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Infection with hepatitis G virus among recipients of plasma products.
@en
type
label
Infection with hepatitis G virus among recipients of plasma products.
@en
prefLabel
Infection with hepatitis G virus among recipients of plasma products.
@en
P2093
P1433
P1476
Infection with hepatitis G virus among recipients of plasma products.
@en
P2093
P304
P356
10.1016/S0140-6736(96)04041-X
P407
P577
1996-11-01T00:00:00Z